CORONA REMEDIES
Smallcap | BSE
Sector
Index
Here's the live share price of Corona Remedies along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-6.67₹ -116.90
As on May 12, 2026, 04:01 PM IST
Corona Remedies Price Performance
Today's LowToday's High
₹1,603.95₹1,951.30
₹1,636.30
52 Weeks' Low52 Weeks' High
₹1,336.95₹1,951.30
₹1,636.30
Open Price
₹1,803.90
Prev. Close
₹1,753.20
Volume
21,708
Corona Remedies Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Corona Remedies | -6.32 | 3.83 | 3.12 | 13.85 | 13.85 | 4.42 | 2.63 |
| Sun Pharmaceutical Industries | -0.24 | 11.74 | 8.70 | 6.34 | 8.56 | 24.54 | 21.31 |
| Divi's Laboratories | -1.02 | 9.31 | 7.59 | 0.73 | 9.34 | 26.00 | 10.32 |
| Torrent Pharmaceuticals | 0.52 | 4.81 | 7.51 | 14.50 | 35.51 | 38.45 | 26.30 |
| Dr. Reddy's Laboratories | -3.08 | 2.83 | 0.20 | 2.88 | 5.25 | 12.45 | 3.67 |
| Cipla | -5.13 | 6.92 | -2.68 | -15.12 | -14.76 | 11.48 | 7.58 |
| Lupin | -8.26 | -3.10 | 1.89 | 9.15 | 8.61 | 42.54 | 13.10 |
| Mankind Pharma | 0.66 | 14.34 | 15.39 | 5.38 | -6.69 | 19.43 | 10.79 |
| Zydus Lifesciences | -0.76 | 0.96 | 3.00 | -1.29 | 3.37 | 21.99 | 7.57 |
| Aurobindo Pharma | 0.35 | 11.12 | 29.62 | 23.15 | 21.78 | 34.63 | 7.93 |
| Laurus Labs | 8.08 | 16.88 | 25.88 | 27.54 | 113.52 | 59.97 | 21.30 |
| Alkem Laboratories | -0.62 | 2.72 | 1.92 | -3.79 | 7.44 | 17.31 | 12.95 |
| Biocon | 5.62 | 16.58 | 6.45 | -3.57 | 21.99 | 17.95 | 0.85 |
| Glenmark Pharmaceuticals | -4.98 | 2.80 | 12.97 | 20.21 | 59.22 | 54.41 | 29.31 |
| Abbott India | 2.31 | 4.58 | 1.64 | -8.97 | -11.57 | 8.25 | 10.79 |
| Anthem Biosciences | 4.15 | 9.67 | 16.19 | 14.62 | 9.58 | 3.10 | 1.85 |
| GlaxoSmithKline Pharmaceuticals | 0.55 | 1.16 | -6.02 | -2.24 | -12.63 | 24.08 | 10.50 |
| Ajanta Pharma | 0.15 | 6.98 | 6.13 | 21.60 | 19.53 | 34.88 | 18.33 |
| Ipca Laboratories | -3.91 | 3.57 | 0.94 | 15.35 | 6.99 | 29.33 | 7.06 |
| J B Chemicals & Pharmaceuticals | -0.48 | 6.59 | 12.55 | 17.10 | 34.84 | 27.74 | 25.17 |
Over the last one year, Corona Remedies has gained 13.85% compared to peers like Sun Pharmaceutical Industries (8.56%), Divi's Laboratories (9.34%), Torrent Pharmaceuticals (35.51%). From a 5 year perspective, Corona Remedies has underperformed peers relative to Sun Pharmaceutical Industries (21.31%) and Divi's Laboratories (10.32%).
Corona Remedies Financials
Corona Remedies Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,740.56 | 1,698.74 |
| 10 | 1,721.96 | 1,699.53 |
| 20 | 1,667.08 | 1,674.17 |
| 50 | 1,611 | 1,615.39 |
| 100 | 1,507.89 | 0 |
| 200 | 753.95 | 0 |
Corona Remedies Share Holding Pattern
In the latest quarter, Corona Remedies remained same as its previous close in promoter holding, while DII stake increased to 7.02%, FII holding rose to 2.25%, and public shareholding moved down to 21.75% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Corona Remedies Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 78,024 | 0.65 | 12.14 | |
| 75,000 | 0.29 | 11.67 | |
| 59,181 | 0.75 | 9.21 | |
| 58,492 | 0.6 | 9.1 | |
| 55,000 | 1.93 | 8.56 | |
| 39,853 | 0.73 | 6.2 |
* Excluding Index & Arbitrage Funds
Corona Remedies Corporate Actions
Date Time | Announcement |
|---|---|
| May 12, 2026, 09:34 PM IST IST | Corona Remedies - Annual Secretarial Compliance Report For The Financial Year Ended March 31, 2026 |
| May 12, 2026, 09:33 PM IST IST | Corona Remedies - Annual Secretarial Compliance Report For The Financial Year Ended March 31, 2026 |
| May 12, 2026, 08:59 PM IST IST | Corona Remedies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| May 12, 2026, 01:16 AM IST IST | Corona Remedies - Announcement under Regulation 30 (LODR)-Investor Presentation |
| May 12, 2026, 12:05 AM IST IST | Corona Remedies - Record Date For The Purpose Of Final Dividend For The F.Y. 2025-26 Is June 19, 2026 |
About Corona Remedies
Corona Remedies Ltd. is a Public Limited Listed company incorporated on 27/08/2004 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24231GJ2004PLC044656 and registration number is 044656. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1403.18 Cr. and Equity Capital is Rs. 61.16 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressCorona House, C Mondeal Business Park, Near Gurudwara, S G Highway, Ahmedabad Gujarat 380059
- Contact
Management
- Dr. Kirtikumar Laxmidas MehtaChairman & Non-Exe.Director
- Mr. Niravkumar Kirtikumar MehtaManaging Director & CEO
- Mr. Ankur Kirtikumar MehtaJoint Managing Director
- Mr. Viral Bhupendrabhai SitwalaWhole Time Director
- Mr. Ameetkumar Hiranyakumar DesaiIndependent Director
- Ms. Monica Hemal KanugaIndependent Director
- Mr. Shirish Gundopant BelapureIndependent Director
- Mr. Bhaskar Vemban IyerIndependent Director
FAQs on Corona Remedies Share Price
What is the share price of Corona Remedies?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Corona Remedies is ₹1,636.30 as on May 12, 2026.
What kind of stock is Corona Remedies?
The Corona Remedies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Corona Remedies?
The market cap of Corona Remedies is ₹10,007.63 Cr as on May 12, 2026.
What are today's High and Low prices of Corona Remedies?
Today’s highest and lowest price of Corona Remedies are ₹1,951.30 and ₹1,603.95.
What are the 52 Week High and 52 Week Low of Corona Remedies?
The 52-week high/low is the highest and lowest price at which Corona Remedies stock has traded in the past 52-week or nearly a year. The 52-week high of Corona Remedies is ₹1,951.30 and 52-week low of Corona Remedies is ₹1,336.95 as on May 12, 2026.
How has the Corona Remedies performed historically in terms of returns?
The Corona Remedies has shown returns of -6.67% over the past day, 3.83% for the past month, 1.37% over 3 months, 13.85% over 1 year, 4.42% across 3 years, and 2.63% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Corona Remedies?
P/E ratio of and PB ratio of Corona Remedies are 54.06 and 14.28 on May 12, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse